COMPARATIVE EFFICIENCY AND SAFETY APPRAISAL OF TWO VACCINES AGAINST TYPE B HEMOPHILIC INFECTION: ACT_HIB AND HIBERIX AMONG CHILDREN
Abstract
The article highlights the results of the research carried out at the department of the vaccine prevention of the Scientific center of children's health RAMS to study the efficiency and safety of vaccination against the type b hemophilic infection (Hib'infection). The authors compared two vaccines applied for the prevention of this infection: Act' Hib and Hiberix. They proved similar efficiency, good tolerance and safety of both vaccines. The authors also made up recommendations for optimized vaccination of the children with different health statuses.
Key words: hemophilic infection, vaccination, children.
Key words: hemophilic infection, vaccination, children.
About the Authors
V.V. Botvin’eva
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
L.S. Namazova-Baranova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
A.G. Gaivoronskaya
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
E.G. Filyanskaya
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
I.Z. Dzhgarkava
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
Review
For citations:
Botvin’eva V., Namazova-Baranova L., Gaivoronskaya A., Filyanskaya E., Dzhgarkava I. COMPARATIVE EFFICIENCY AND SAFETY APPRAISAL OF TWO VACCINES AGAINST TYPE B HEMOPHILIC INFECTION: ACT_HIB AND HIBERIX AMONG CHILDREN. Pediatric pharmacology. 2009;6(3):13-17.
Views:
706
Email this article 